nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS2—type 2 diabetes mellitus	0.189	1	CbGaD
Meclofenamic acid—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0643	0.132	CbGbCtD
Meclofenamic acid—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0643	0.132	CbGbCtD
Meclofenamic acid—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0594	0.122	CbGbCtD
Meclofenamic acid—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0564	0.115	CbGbCtD
Meclofenamic acid—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0503	0.103	CbGbCtD
Meclofenamic acid—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0488	0.0998	CbGbCtD
Meclofenamic acid—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0467	0.0957	CbGbCtD
Meclofenamic acid—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0427	0.0875	CbGbCtD
Meclofenamic acid—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0289	0.0591	CbGbCtD
Meclofenamic acid—SLC22A6—Losartan—type 2 diabetes mellitus	0.0264	0.0541	CbGbCtD
Meclofenamic acid—PTGS2—leg—type 2 diabetes mellitus	0.00207	0.0684	CbGeAlD
Meclofenamic acid—KCNQ3—cardiovascular system—type 2 diabetes mellitus	0.00198	0.0654	CbGeAlD
Meclofenamic acid—PTGS2—hindlimb—type 2 diabetes mellitus	0.00185	0.0611	CbGeAlD
Meclofenamic acid—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.00161	0.0532	CbGeAlD
Meclofenamic acid—ALOX5—islet of Langerhans—type 2 diabetes mellitus	0.00142	0.0469	CbGeAlD
Meclofenamic acid—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.0013	0.0428	CbGeAlD
Meclofenamic acid—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00129	0.0426	CbGeAlD
Meclofenamic acid—SLCO1C1—kidney—type 2 diabetes mellitus	0.00124	0.0409	CbGeAlD
Meclofenamic acid—PTGS1—artery—type 2 diabetes mellitus	0.00118	0.0392	CbGeAlD
Meclofenamic acid—PTGS2—artery—type 2 diabetes mellitus	0.00113	0.0374	CbGeAlD
Meclofenamic acid—AKR1C3—pancreas—type 2 diabetes mellitus	0.00113	0.0374	CbGeAlD
Meclofenamic acid—SLCO1C1—adipose tissue—type 2 diabetes mellitus	0.00112	0.0369	CbGeAlD
Meclofenamic acid—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.00111	0.0366	CbGeAlD
Meclofenamic acid—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.0011	0.0365	CbGeAlD
Meclofenamic acid—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.00103	0.0339	CbGeAlD
Meclofenamic acid—ALOX5—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0339	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—EDNRA—type 2 diabetes mellitus	0.00101	0.238	CrCbGaD
Meclofenamic acid—PTGS1—endothelium—type 2 diabetes mellitus	0.001	0.0331	CbGeAlD
Meclofenamic acid—ALOX5—pancreas—type 2 diabetes mellitus	0.000997	0.0329	CbGeAlD
Meclofenamic acid—PTGS2—endothelium—type 2 diabetes mellitus	0.000956	0.0316	CbGeAlD
Meclofenamic acid—ALOX5—adipose tissue—type 2 diabetes mellitus	0.000904	0.0299	CbGeAlD
Meclofenamic acid—AKR1C3—liver—type 2 diabetes mellitus	0.000719	0.0238	CbGeAlD
Meclofenamic acid—ALOX5—liver—type 2 diabetes mellitus	0.000634	0.021	CbGeAlD
Meclofenamic acid—Niclosamide—CYP1A2—type 2 diabetes mellitus	0.000618	0.146	CrCbGaD
Meclofenamic acid—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000544	0.018	CbGeAlD
Meclofenamic acid—Lumiracoxib—CYP1A2—type 2 diabetes mellitus	0.000468	0.11	CrCbGaD
Meclofenamic acid—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000412	0.0136	CbGeAlD
Meclofenamic acid—PTGS1—kidney—type 2 diabetes mellitus	0.000403	0.0133	CbGeAlD
Meclofenamic acid—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000393	0.013	CbGeAlD
Meclofenamic acid—PTGS2—kidney—type 2 diabetes mellitus	0.000385	0.0127	CbGeAlD
Meclofenamic acid—PTGS2—pancreas—type 2 diabetes mellitus	0.000382	0.0126	CbGeAlD
Meclofenamic acid—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000363	0.012	CbGeAlD
Meclofenamic acid—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000347	0.0115	CbGeAlD
Meclofenamic acid—Nausea—Acarbose—type 2 diabetes mellitus	0.000347	0.00205	CcSEcCtD
Meclofenamic acid—Constipation—Glipizide—type 2 diabetes mellitus	0.000345	0.00204	CcSEcCtD
Meclofenamic acid—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000345	0.00204	CcSEcCtD
Meclofenamic acid—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00034	0.00202	CcSEcCtD
Meclofenamic acid—Insomnia—Glimepiride—type 2 diabetes mellitus	0.00034	0.00202	CcSEcCtD
Meclofenamic acid—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000339	0.00201	CcSEcCtD
Meclofenamic acid—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000339	0.00201	CcSEcCtD
Meclofenamic acid—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000339	0.00201	CcSEcCtD
Meclofenamic acid—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000338	0.002	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.000335	0.00199	CcSEcCtD
Meclofenamic acid—Nausea—Nateglinide—type 2 diabetes mellitus	0.000334	0.00198	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000334	0.00198	CcSEcCtD
Meclofenamic acid—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000333	0.00197	CcSEcCtD
Meclofenamic acid—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000333	0.00197	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000332	0.00197	CcSEcCtD
Meclofenamic acid—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000331	0.00196	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00033	0.00195	CcSEcCtD
Meclofenamic acid—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000327	0.00194	CcSEcCtD
Meclofenamic acid—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00193	CcSEcCtD
Meclofenamic acid—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000326	0.00193	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000325	0.00192	CcSEcCtD
Meclofenamic acid—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000324	0.00192	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000324	0.00192	CcSEcCtD
Meclofenamic acid—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000324	0.00192	CcSEcCtD
Meclofenamic acid—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000323	0.00192	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000322	0.00191	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000322	0.00191	CcSEcCtD
Meclofenamic acid—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000321	0.0019	CcSEcCtD
Meclofenamic acid—Urticaria—Glipizide—type 2 diabetes mellitus	0.00032	0.0019	CcSEcCtD
Meclofenamic acid—Renal failure—Losartan—type 2 diabetes mellitus	0.000319	0.00189	CcSEcCtD
Meclofenamic acid—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000319	0.00189	CcSEcCtD
Meclofenamic acid—Alopecia—Valsartan—type 2 diabetes mellitus	0.000318	0.00189	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000318	0.00189	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000317	0.00188	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000316	0.00187	CcSEcCtD
Meclofenamic acid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000315	0.00187	CcSEcCtD
Meclofenamic acid—Alopecia—Orlistat—type 2 diabetes mellitus	0.000315	0.00186	CcSEcCtD
Meclofenamic acid—Oedema—Glyburide—type 2 diabetes mellitus	0.00031	0.00184	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00031	0.00184	CcSEcCtD
Meclofenamic acid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00031	0.00184	CcSEcCtD
Meclofenamic acid—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000309	0.00183	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000309	0.00183	CcSEcCtD
Meclofenamic acid—Malaise—Gliclazide—type 2 diabetes mellitus	0.000308	0.00182	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000308	0.00182	CcSEcCtD
Meclofenamic acid—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000307	0.00182	CcSEcCtD
Meclofenamic acid—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000307	0.00182	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000307	0.00182	CcSEcCtD
Meclofenamic acid—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000306	0.00181	CcSEcCtD
Meclofenamic acid—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000305	0.00181	CcSEcCtD
Meclofenamic acid—Lumiracoxib—PTGS2—type 2 diabetes mellitus	0.000304	0.0715	CrCbGaD
Meclofenamic acid—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000303	0.00179	CcSEcCtD
Meclofenamic acid—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000302	0.00179	CcSEcCtD
Meclofenamic acid—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000299	0.00177	CcSEcCtD
Meclofenamic acid—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00176	CcSEcCtD
Meclofenamic acid—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000297	0.00176	CcSEcCtD
Meclofenamic acid—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00176	CcSEcCtD
Meclofenamic acid—Anorexia—Glyburide—type 2 diabetes mellitus	0.000296	0.00175	CcSEcCtD
Meclofenamic acid—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000296	0.00175	CcSEcCtD
Meclofenamic acid—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000295	0.00175	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000293	0.00174	CcSEcCtD
Meclofenamic acid—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000293	0.00173	CcSEcCtD
Meclofenamic acid—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000292	0.00173	CcSEcCtD
Meclofenamic acid—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000292	0.00173	CcSEcCtD
Meclofenamic acid—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00029	0.00172	CcSEcCtD
Meclofenamic acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.00029	0.00171	CcSEcCtD
Meclofenamic acid—Asthenia—Glipizide—type 2 diabetes mellitus	0.000289	0.00171	CcSEcCtD
Meclofenamic acid—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000289	0.00171	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000288	0.0017	CcSEcCtD
Meclofenamic acid—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000287	0.0017	CcSEcCtD
Meclofenamic acid—Pruritus—Glipizide—type 2 diabetes mellitus	0.000285	0.00169	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00166	CcSEcCtD
Meclofenamic acid—Malaise—Orlistat—type 2 diabetes mellitus	0.00028	0.00166	CcSEcCtD
Meclofenamic acid—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000279	0.00165	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000278	0.00164	CcSEcCtD
Meclofenamic acid—Palpitations—Valsartan—type 2 diabetes mellitus	0.000277	0.00164	CcSEcCtD
Meclofenamic acid—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000277	0.00164	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000276	0.00163	CcSEcCtD
Meclofenamic acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000276	0.00163	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000276	0.00163	CcSEcCtD
Meclofenamic acid—Palpitations—Orlistat—type 2 diabetes mellitus	0.000274	0.00162	CcSEcCtD
Meclofenamic acid—Renal failure—Ramipril—type 2 diabetes mellitus	0.000274	0.00162	CcSEcCtD
Meclofenamic acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000274	0.00162	CcSEcCtD
Meclofenamic acid—Tinnitus—Losartan—type 2 diabetes mellitus	0.000272	0.00161	CcSEcCtD
Meclofenamic acid—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000271	0.00161	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000271	0.0016	CcSEcCtD
Meclofenamic acid—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00027	0.0016	CcSEcCtD
Meclofenamic acid—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00027	0.0016	CcSEcCtD
Meclofenamic acid—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00027	0.0016	CcSEcCtD
Meclofenamic acid—Vision blurred—Metformin—type 2 diabetes mellitus	0.000269	0.00159	CcSEcCtD
Meclofenamic acid—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000269	0.00159	CcSEcCtD
Meclofenamic acid—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00159	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000268	0.00159	CcSEcCtD
Meclofenamic acid—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000266	0.00158	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000265	0.00157	CcSEcCtD
Meclofenamic acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000264	0.00157	CcSEcCtD
Meclofenamic acid—Discomfort—Orlistat—type 2 diabetes mellitus	0.000261	0.00154	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00026	0.00154	CcSEcCtD
Meclofenamic acid—Malaise—Metformin—type 2 diabetes mellitus	0.000258	0.00153	CcSEcCtD
Meclofenamic acid—Alopecia—Losartan—type 2 diabetes mellitus	0.000258	0.00153	CcSEcCtD
Meclofenamic acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000257	0.00152	CcSEcCtD
Meclofenamic acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000257	0.00152	CcSEcCtD
Meclofenamic acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000256	0.00152	CcSEcCtD
Meclofenamic acid—Oedema—Valsartan—type 2 diabetes mellitus	0.000256	0.00152	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000256	0.00151	CcSEcCtD
Meclofenamic acid—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000254	0.0015	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000254	0.0015	CcSEcCtD
Meclofenamic acid—Oedema—Orlistat—type 2 diabetes mellitus	0.000253	0.0015	CcSEcCtD
Meclofenamic acid—Palpitations—Metformin—type 2 diabetes mellitus	0.000252	0.00149	CcSEcCtD
Meclofenamic acid—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000252	0.00149	CcSEcCtD
Meclofenamic acid—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00025	0.00148	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00025	0.00148	CcSEcCtD
Meclofenamic acid—Urticaria—Glyburide—type 2 diabetes mellitus	0.000247	0.00146	CcSEcCtD
Meclofenamic acid—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000245	0.00145	CcSEcCtD
Meclofenamic acid—Anorexia—Valsartan—type 2 diabetes mellitus	0.000244	0.00145	CcSEcCtD
Meclofenamic acid—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000244	0.00144	CcSEcCtD
Meclofenamic acid—PTGS2—liver—type 2 diabetes mellitus	0.000243	0.00804	CbGeAlD
Meclofenamic acid—Malaise—Irbesartan—type 2 diabetes mellitus	0.000243	0.00144	CcSEcCtD
Meclofenamic acid—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000241	0.00143	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000241	0.00142	CcSEcCtD
Meclofenamic acid—Discomfort—Metformin—type 2 diabetes mellitus	0.00024	0.00142	CcSEcCtD
Meclofenamic acid—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00024	0.00142	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—type 2 diabetes mellitus	0.00024	0.0565	CrCbGaD
Meclofenamic acid—Nausea—Glipizide—type 2 diabetes mellitus	0.00024	0.00142	CcSEcCtD
Meclofenamic acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000239	0.00142	CcSEcCtD
Meclofenamic acid—Vision blurred—Losartan—type 2 diabetes mellitus	0.000239	0.00142	CcSEcCtD
Meclofenamic acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000239	0.00141	CcSEcCtD
Meclofenamic acid—Constipation—Gliclazide—type 2 diabetes mellitus	0.000238	0.00141	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000236	0.0014	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000235	0.00139	CcSEcCtD
Meclofenamic acid—Oedema—Metformin—type 2 diabetes mellitus	0.000233	0.00138	CcSEcCtD
Meclofenamic acid—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000233	0.00138	CcSEcCtD
Meclofenamic acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000232	0.00138	CcSEcCtD
Meclofenamic acid—Insomnia—Valsartan—type 2 diabetes mellitus	0.000232	0.00137	CcSEcCtD
Meclofenamic acid—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00023	0.00136	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00023	0.00136	CcSEcCtD
Meclofenamic acid—Insomnia—Orlistat—type 2 diabetes mellitus	0.000229	0.00136	CcSEcCtD
Meclofenamic acid—Malaise—Losartan—type 2 diabetes mellitus	0.000229	0.00135	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000228	0.00135	CcSEcCtD
Meclofenamic acid—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000227	0.00135	CcSEcCtD
Meclofenamic acid—Leukopenia—Losartan—type 2 diabetes mellitus	0.000227	0.00134	CcSEcCtD
Meclofenamic acid—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000227	0.00134	CcSEcCtD
Meclofenamic acid—Palpitations—Losartan—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Meclofenamic acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000224	0.00132	CcSEcCtD
Meclofenamic acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000223	0.00132	CcSEcCtD
Meclofenamic acid—Asthenia—Glyburide—type 2 diabetes mellitus	0.000223	0.00132	CcSEcCtD
Meclofenamic acid—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000223	0.00132	CcSEcCtD
Meclofenamic acid—Anorexia—Metformin—type 2 diabetes mellitus	0.000222	0.00132	CcSEcCtD
Meclofenamic acid—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000221	0.00131	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000221	0.00131	CcSEcCtD
Meclofenamic acid—Alopecia—Ramipril—type 2 diabetes mellitus	0.000221	0.00131	CcSEcCtD
Meclofenamic acid—Fatigue—Valsartan—type 2 diabetes mellitus	0.000221	0.00131	CcSEcCtD
Meclofenamic acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00022	0.0013	CcSEcCtD
Meclofenamic acid—Oedema—Irbesartan—type 2 diabetes mellitus	0.00022	0.0013	CcSEcCtD
Meclofenamic acid—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00022	0.0013	CcSEcCtD
Meclofenamic acid—Pruritus—Glyburide—type 2 diabetes mellitus	0.00022	0.0013	CcSEcCtD
Meclofenamic acid—Constipation—Valsartan—type 2 diabetes mellitus	0.000219	0.0013	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000218	0.00129	CcSEcCtD
Meclofenamic acid—Fatigue—Orlistat—type 2 diabetes mellitus	0.000218	0.00129	CcSEcCtD
Meclofenamic acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00128	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP2E1—type 2 diabetes mellitus	0.000214	0.0505	CrCbGaD
Meclofenamic acid—Discomfort—Losartan—type 2 diabetes mellitus	0.000213	0.00126	CcSEcCtD
Meclofenamic acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000212	0.00126	CcSEcCtD
Meclofenamic acid—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00021	0.00124	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000209	0.00124	CcSEcCtD
Meclofenamic acid—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000209	0.00124	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000208	0.00123	CcSEcCtD
Meclofenamic acid—Oedema—Losartan—type 2 diabetes mellitus	0.000207	0.00123	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000207	0.00123	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP1A2—type 2 diabetes mellitus	0.000204	0.048	CrCbGaD
Meclofenamic acid—Urticaria—Valsartan—type 2 diabetes mellitus	0.000203	0.0012	CcSEcCtD
Meclofenamic acid—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000203	0.0012	CcSEcCtD
Meclofenamic acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000202	0.0012	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000202	0.0012	CcSEcCtD
Meclofenamic acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000202	0.00119	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000201	0.00119	CcSEcCtD
Meclofenamic acid—Fatigue—Metformin—type 2 diabetes mellitus	0.000201	0.00119	CcSEcCtD
Meclofenamic acid—Urticaria—Orlistat—type 2 diabetes mellitus	0.000201	0.00119	CcSEcCtD
Meclofenamic acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.0002	0.00118	CcSEcCtD
Meclofenamic acid—Asthenia—Gliclazide—type 2 diabetes mellitus	0.0002	0.00118	CcSEcCtD
Meclofenamic acid—Constipation—Metformin—type 2 diabetes mellitus	0.000199	0.00118	CcSEcCtD
Meclofenamic acid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000198	0.00117	CcSEcCtD
Meclofenamic acid—Anorexia—Losartan—type 2 diabetes mellitus	0.000197	0.00117	CcSEcCtD
Meclofenamic acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000197	0.00117	CcSEcCtD
Meclofenamic acid—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000197	0.00117	CcSEcCtD
Meclofenamic acid—Malaise—Ramipril—type 2 diabetes mellitus	0.000196	0.00116	CcSEcCtD
Meclofenamic acid—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000195	0.00115	CcSEcCtD
Meclofenamic acid—Palpitations—Ramipril—type 2 diabetes mellitus	0.000192	0.00114	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000192	0.00114	CcSEcCtD
Meclofenamic acid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000191	0.00113	CcSEcCtD
Meclofenamic acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000191	0.00113	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000191	0.00113	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00019	0.00112	CcSEcCtD
Meclofenamic acid—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00019	0.00112	CcSEcCtD
Meclofenamic acid—Constipation—Irbesartan—type 2 diabetes mellitus	0.000188	0.00111	CcSEcCtD
Meclofenamic acid—Insomnia—Losartan—type 2 diabetes mellitus	0.000187	0.00111	CcSEcCtD
Meclofenamic acid—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000186	0.0011	CcSEcCtD
Meclofenamic acid—Urticaria—Metformin—type 2 diabetes mellitus	0.000185	0.0011	CcSEcCtD
Meclofenamic acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000184	0.00109	CcSEcCtD
Meclofenamic acid—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000184	0.00109	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—type 2 diabetes mellitus	0.000184	0.0433	CrCbGaD
Meclofenamic acid—Asthenia—Valsartan—type 2 diabetes mellitus	0.000184	0.00109	CcSEcCtD
Meclofenamic acid—Discomfort—Ramipril—type 2 diabetes mellitus	0.000183	0.00108	CcSEcCtD
Meclofenamic acid—Asthenia—Orlistat—type 2 diabetes mellitus	0.000182	0.00107	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000181	0.00107	CcSEcCtD
Meclofenamic acid—Pruritus—Valsartan—type 2 diabetes mellitus	0.000181	0.00107	CcSEcCtD
Meclofenamic acid—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00018	0.00107	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00018	0.00107	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—type 2 diabetes mellitus	0.000179	0.0422	CrCbGaD
Meclofenamic acid—Pruritus—Orlistat—type 2 diabetes mellitus	0.000179	0.00106	CcSEcCtD
Meclofenamic acid—Fatigue—Losartan—type 2 diabetes mellitus	0.000179	0.00106	CcSEcCtD
Meclofenamic acid—Oedema—Ramipril—type 2 diabetes mellitus	0.000178	0.00105	CcSEcCtD
Meclofenamic acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000177	0.00105	CcSEcCtD
Meclofenamic acid—Constipation—Losartan—type 2 diabetes mellitus	0.000177	0.00105	CcSEcCtD
Meclofenamic acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000175	0.00104	CcSEcCtD
Meclofenamic acid—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000175	0.00104	CcSEcCtD
Meclofenamic acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000174	0.00103	CcSEcCtD
Meclofenamic acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000173	0.00103	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000171	0.00101	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000169	0.001	CcSEcCtD
Meclofenamic acid—Anorexia—Ramipril—type 2 diabetes mellitus	0.000169	0.001	CcSEcCtD
Meclofenamic acid—Asthenia—Metformin—type 2 diabetes mellitus	0.000167	0.000991	CcSEcCtD
Meclofenamic acid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000166	0.00098	CcSEcCtD
Meclofenamic acid—Pruritus—Metformin—type 2 diabetes mellitus	0.000165	0.000977	CcSEcCtD
Meclofenamic acid—Urticaria—Losartan—type 2 diabetes mellitus	0.000165	0.000974	CcSEcCtD
Meclofenamic acid—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000164	0.000969	CcSEcCtD
Meclofenamic acid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000163	0.000964	CcSEcCtD
Meclofenamic acid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000161	0.000953	CcSEcCtD
Meclofenamic acid—Insomnia—Ramipril—type 2 diabetes mellitus	0.000161	0.000951	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ALB—type 2 diabetes mellitus	0.00016	0.0376	CrCbGaD
Meclofenamic acid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00016	0.000945	CcSEcCtD
Meclofenamic acid—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000159	0.000944	CcSEcCtD
Meclofenamic acid—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000158	0.000935	CcSEcCtD
Meclofenamic acid—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000156	0.000922	CcSEcCtD
Meclofenamic acid—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000154	0.000914	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000153	0.000908	CcSEcCtD
Meclofenamic acid—Fatigue—Ramipril—type 2 diabetes mellitus	0.000153	0.000906	CcSEcCtD
Meclofenamic acid—Nausea—Valsartan—type 2 diabetes mellitus	0.000152	0.000901	CcSEcCtD
Meclofenamic acid—Constipation—Ramipril—type 2 diabetes mellitus	0.000152	0.000899	CcSEcCtD
Meclofenamic acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000151	0.000891	CcSEcCtD
Meclofenamic acid—Nausea—Orlistat—type 2 diabetes mellitus	0.00015	0.00089	CcSEcCtD
Meclofenamic acid—Asthenia—Losartan—type 2 diabetes mellitus	0.000149	0.00088	CcSEcCtD
Meclofenamic acid—Vomiting—Metformin—type 2 diabetes mellitus	0.000148	0.000878	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS2—type 2 diabetes mellitus	0.000148	0.0348	CrCbGaD
Meclofenamic acid—Pruritus—Losartan—type 2 diabetes mellitus	0.000147	0.000868	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000146	0.000866	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000145	0.00086	CcSEcCtD
Meclofenamic acid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000142	0.000839	CcSEcCtD
Meclofenamic acid—Urticaria—Ramipril—type 2 diabetes mellitus	0.000141	0.000835	CcSEcCtD
Meclofenamic acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00014	0.000831	CcSEcCtD
Meclofenamic acid—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00014	0.000828	CcSEcCtD
Meclofenamic acid—Nausea—Metformin—type 2 diabetes mellitus	0.000138	0.00082	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP3A4—type 2 diabetes mellitus	0.000135	0.0318	CrCbGaD
Meclofenamic acid—Diclofenac—PTGS2—type 2 diabetes mellitus	0.000132	0.0311	CrCbGaD
Meclofenamic acid—Vomiting—Losartan—type 2 diabetes mellitus	0.000132	0.00078	CcSEcCtD
Meclofenamic acid—Salicylic acid—ALB—type 2 diabetes mellitus	0.000132	0.031	CrCbGaD
Meclofenamic acid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000131	0.000774	CcSEcCtD
Meclofenamic acid—Asthenia—Ramipril—type 2 diabetes mellitus	0.000127	0.000754	CcSEcCtD
Meclofenamic acid—Pruritus—Ramipril—type 2 diabetes mellitus	0.000126	0.000744	CcSEcCtD
Meclofenamic acid—Nausea—Losartan—type 2 diabetes mellitus	0.000123	0.000728	CcSEcCtD
Meclofenamic acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000121	0.000719	CcSEcCtD
Meclofenamic acid—Diclofenac—ALB—type 2 diabetes mellitus	0.000118	0.0277	CrCbGaD
Meclofenamic acid—Vomiting—Ramipril—type 2 diabetes mellitus	0.000113	0.000669	CcSEcCtD
Meclofenamic acid—Nausea—Ramipril—type 2 diabetes mellitus	0.000105	0.000625	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—IRS1—type 2 diabetes mellitus	1.67e-05	0.00014	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPARA—type 2 diabetes mellitus	1.66e-05	0.000139	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPARA—type 2 diabetes mellitus	1.65e-05	0.000138	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HK1—type 2 diabetes mellitus	1.65e-05	0.000138	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.64e-05	0.000137	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.63e-05	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.62e-05	0.000136	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	1.62e-05	0.000136	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.61e-05	0.000135	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.61e-05	0.000135	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.61e-05	0.000135	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALDOB—type 2 diabetes mellitus	1.61e-05	0.000135	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AGT—type 2 diabetes mellitus	1.61e-05	0.000134	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AGT—type 2 diabetes mellitus	1.6e-05	0.000134	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—INS—type 2 diabetes mellitus	1.6e-05	0.000134	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	1.6e-05	0.000134	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	1.59e-05	0.000133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.59e-05	0.000133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GCKR—type 2 diabetes mellitus	1.59e-05	0.000133	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-05	0.000132	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—APOE—type 2 diabetes mellitus	1.57e-05	0.000132	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CALM1—type 2 diabetes mellitus	1.57e-05	0.000132	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.57e-05	0.000132	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	1.57e-05	0.000131	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.57e-05	0.000131	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	1.57e-05	0.000131	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—APOE—type 2 diabetes mellitus	1.57e-05	0.000131	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—LPL—type 2 diabetes mellitus	1.56e-05	0.000131	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.56e-05	0.000131	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—APOA1—type 2 diabetes mellitus	1.55e-05	0.00013	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—APOA1—type 2 diabetes mellitus	1.55e-05	0.00013	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT2—type 2 diabetes mellitus	1.54e-05	0.000129	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.53e-05	0.000128	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.53e-05	0.000128	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	1.53e-05	0.000128	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.52e-05	0.000127	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.51e-05	0.000127	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GLP1R—type 2 diabetes mellitus	1.5e-05	0.000125	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	1.47e-05	0.000123	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SERPINE1—type 2 diabetes mellitus	1.47e-05	0.000123	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.47e-05	0.000123	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	1.46e-05	0.000122	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.45e-05	0.000121	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.44e-05	0.000121	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.44e-05	0.000121	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RBP4—type 2 diabetes mellitus	1.42e-05	0.000119	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.42e-05	0.000118	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.41e-05	0.000118	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.41e-05	0.000118	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—C3—type 2 diabetes mellitus	1.41e-05	0.000118	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NOS3—type 2 diabetes mellitus	1.4e-05	0.000117	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3R1—type 2 diabetes mellitus	1.4e-05	0.000117	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.4e-05	0.000117	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	1.38e-05	0.000116	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.38e-05	0.000115	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPARG—type 2 diabetes mellitus	1.37e-05	0.000115	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	1.37e-05	0.000115	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	1.37e-05	0.000115	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPARG—type 2 diabetes mellitus	1.36e-05	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.35e-05	0.000113	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—INS—type 2 diabetes mellitus	1.34e-05	0.000113	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.34e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	1.34e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.34e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—INS—type 2 diabetes mellitus	1.34e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AGT—type 2 diabetes mellitus	1.34e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-05	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	1.32e-05	0.000111	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.31e-05	0.00011	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APOE—type 2 diabetes mellitus	1.31e-05	0.00011	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—LEP—type 2 diabetes mellitus	1.31e-05	0.00011	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.3e-05	0.000109	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.3e-05	0.000109	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.3e-05	0.000108	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.29e-05	0.000108	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—type 2 diabetes mellitus	1.28e-05	0.000107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.28e-05	0.000107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.28e-05	0.000107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.27e-05	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.26e-05	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.26e-05	0.000105	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.24e-05	0.000104	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.24e-05	0.000103	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.23e-05	0.000103	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ALB—type 2 diabetes mellitus	1.23e-05	0.000103	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ALB—type 2 diabetes mellitus	1.23e-05	0.000103	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.22e-05	0.000102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.2e-05	0.000101	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.2e-05	0.0001	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-05	0.0001	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-05	0.0001	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-05	0.0001	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.19e-05	9.94e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-05	9.87e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-05	9.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.17e-05	9.83e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NOS3—type 2 diabetes mellitus	1.17e-05	9.83e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.17e-05	9.83e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.17e-05	9.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.16e-05	9.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.16e-05	9.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.15e-05	9.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.14e-05	9.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.13e-05	9.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.13e-05	9.49e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—INS—type 2 diabetes mellitus	1.12e-05	9.37e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.11e-05	9.28e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.1e-05	9.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.1e-05	9.19e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.09e-05	9.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.09e-05	9.09e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.09e-05	9.09e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.08e-05	9.07e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.08e-05	9.06e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.08e-05	9.06e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.08e-05	9.06e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—type 2 diabetes mellitus	1.08e-05	9.02e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—type 2 diabetes mellitus	1.07e-05	8.99e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.07e-05	8.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.06e-05	8.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.06e-05	8.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.06e-05	8.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.06e-05	8.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.06e-05	8.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.05e-05	8.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.05e-05	8.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.05e-05	8.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-05	8.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.04e-05	8.68e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SRC—type 2 diabetes mellitus	1.04e-05	8.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.03e-05	8.65e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.03e-05	8.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.03e-05	8.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.02e-05	8.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.01e-05	8.46e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1e-05	8.4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1e-05	8.37e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	9.83e-06	8.23e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.82e-06	8.22e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.82e-06	8.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.52e-06	7.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	9.49e-06	7.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	9.49e-06	7.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	9.49e-06	7.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	9.32e-06	7.8e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFB1—type 2 diabetes mellitus	9.27e-06	7.76e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.24e-06	7.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	9.24e-06	7.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.11e-06	7.63e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—type 2 diabetes mellitus	9.09e-06	7.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	9.04e-06	7.57e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	8.94e-06	7.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.94e-06	7.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	8.9e-06	7.45e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	8.78e-06	7.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	8.68e-06	7.27e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	8.59e-06	7.19e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	8.59e-06	7.19e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	8.55e-06	7.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	8.52e-06	7.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	8.37e-06	7.01e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.33e-06	6.98e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	8.29e-06	6.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	8.28e-06	6.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	8.23e-06	6.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	8.23e-06	6.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	8.14e-06	6.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APOB—type 2 diabetes mellitus	8.08e-06	6.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	7.97e-06	6.67e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	7.94e-06	6.65e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.88e-06	6.59e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.79e-06	6.52e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	7.73e-06	6.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LPL—type 2 diabetes mellitus	7.71e-06	6.46e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.63e-06	6.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	7.55e-06	6.32e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7.33e-06	6.13e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.26e-06	6.08e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	7.24e-06	6.06e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	7.19e-06	6.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CCR5—type 2 diabetes mellitus	7.11e-06	5.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	7.09e-06	5.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.09e-06	5.94e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.07e-06	5.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	7.06e-06	5.91e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—type 2 diabetes mellitus	6.98e-06	5.85e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.97e-06	5.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.96e-06	5.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.94e-06	5.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	6.84e-06	5.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	6.82e-06	5.71e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	6.77e-06	5.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.74e-06	5.65e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	6.62e-06	5.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IRS2—type 2 diabetes mellitus	6.61e-06	5.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	6.58e-06	5.51e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.49e-06	5.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALM1—type 2 diabetes mellitus	6.49e-06	5.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.47e-06	5.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.46e-06	5.41e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	6.44e-06	5.4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.39e-06	5.35e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.36e-06	5.33e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	6.32e-06	5.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	6.3e-06	5.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	6.14e-06	5.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.06e-06	5.07e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS2—type 2 diabetes mellitus	6.02e-06	5.04e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.94e-06	4.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.83e-06	4.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.82e-06	4.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.77e-06	4.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	5.71e-06	4.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.53e-06	4.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—INS—type 2 diabetes mellitus	5.52e-06	4.62e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.43e-06	4.55e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—type 2 diabetes mellitus	5.42e-06	4.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.41e-06	4.53e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	5.4e-06	4.52e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.35e-06	4.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.34e-06	4.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.34e-06	4.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.11e-06	4.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.11e-06	4.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	5.07e-06	4.25e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.89e-06	4.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.84e-06	4.06e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.84e-06	4.06e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.72e-06	3.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.67e-06	3.91e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.63e-06	3.87e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.51e-06	3.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.24e-06	3.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.06e-06	3.4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	4.06e-06	3.4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.58e-06	3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.2e-06	2.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.14e-06	2.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.41e-06	2.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-06	1.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.23e-06	1.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.86e-06	1.56e-05	CbGpPWpGaD
